TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Urinary phosphate-to-creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: healthy snacking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TTR stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average serum TTR increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right colonic cleansing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incomplete colonoscopies rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Taste scores for PEG‐EOS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Healing within 180 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of minor local complications
Endpoint domain: Adverse events/effects
Primary endpoint: failure of nasogastric tube placement or replacement
Endpoint domain: Adverse events/effects
Primary endpoint: tube dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: self-reported intake of fruits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: self-reported intake of vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: self-reported intake of milk/dairy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rejection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduced risk of colorectal cancer (CRC)
Endpoint domain: Mortality/survival
Primary endpoint: Gastric motility suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Endoscopist procedure favorability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate intake of n-3 and n-6 long-chain polyunsaturated fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serious recurrence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of doctors willing to refer patients for surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean lnRHI increase after ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preference for recall method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to EAU and AUA guideline recommendations for BCG use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration of BCG maintenance therapy scheduled
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of BCG maintenance discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: graft placement success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: persistent filling of the aneurysm sac
Endpoint domain: Adverse events/effects
Primary endpoint: Acne scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Physician Global Aesthetic Improvement Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: between-group difference of norepinephrine dose needed to achieve target mean arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ability to integrate disconfirmatory evidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical wound outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Bradykinesia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rigidity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of unplanned ICU admissions
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of UPCR compared with baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Residual UPCR < 1.0 g/gCr at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rates of minor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: mean CFUs in conjunctival cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: mean CFUs in eyelid cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: rate of positive aqueous cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Final and standardized examination scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: GH response to exercise and nocturnal pulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean maximum temperature difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ccr level after cisplatin infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: dislocation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hemoglobin (Hb) concentration 4 weeks after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PMCT delay in lower extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: intellectual function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: motor function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vmca
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in serum ALT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Reduction in serum GGT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Expression of TLR2 on AM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lower-extremity goniometric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consent to continue (CTC)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pelvic inflammatory disease
Endpoint domain: Adverse events/effects
Primary endpoint: Spontaneous abortion
Endpoint domain: Adverse events/effects
Primary endpoint: Continuous abstinence at 12 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cigarette consumption (cigarettes per day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lung cancer rates
Endpoint domain: Mortality/survival
Primary endpoint: Range of Motion (AROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking abstinence at post-treatment assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking abstinence at one-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking abstinence at six-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relapse-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulty awakening score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Downward displacement of ureteral catheters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: normal expressive language abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specific language impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of one or more ETDRS lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDE recommendation and performance rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children in remission (PUCAI < 10) at Week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ΔΔQTcF values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SSS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to CID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidences of moderate-to-severe exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systolic hypotension incidence
Endpoint domain: Adverse events/effects
Primary endpoint: bradycardia incidence
Endpoint domain: Adverse events/effects
Primary endpoint: mild hypoxemia incidence
Endpoint domain: Adverse events/effects
Primary endpoint: severe hypoxemia incidence
Endpoint domain: Adverse events/effects
Primary endpoint: satisfaction of anesthetist and gastroscopist
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CET activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: intimal hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Recovery rate after 3, 6, and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfactory and painless erectile function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erectile function return time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partner satisfaction with erections
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage excess volume (PEV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heaviness and tightness sensations
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mobility disability risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alleviation of LID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of irritation caused by tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective effectiveness of the therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of the first cry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated glycolytic energy contribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active range of motion increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional motor abilities improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: haematocrit decrease duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: plasma viscosity increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: latency of vertigo appearance/disappearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: duration of vertigo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: European Evaluation of Vertigo questionnaire parameters
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: attendance rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: proportion of individuals achieving a weight loss of 5% or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breath freshening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to control blood pressure response to surgical stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of incremental anesthetic increases required
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: End tidal/inspired drug concentration ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of psychotic syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcomes of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient improvement ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Illness ratings of patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Platelet reactivity (P2Y12 reaction units)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in treadmill walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CCCQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Responder rates on Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients alive at 12 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Irritancy of n-butanol
Endpoint domain: Adverse events/effects
Primary endpoint: Progression in disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MR T2 lesion volume changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricle diastolic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Significant ventricular arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Levels of LH, T, and PRL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: maternal anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: level of hip worries
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: UFC AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PRL AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: In-field tumor responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PPE use knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived barriers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NEI‐VFQ composite score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: treatment success rates based on perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDRD eGFR decline rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: C-G CrCl decline rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sensitivity of tumor classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of tumor classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive prognostic value of tumor classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage of engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of exudate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of regrafting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge regarding NGT placement verification
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NGT care auditing procedure
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: increased connectivity between dlPFC and brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: persistent lateral defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: headache pain decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of headache resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum total and LDL cholesterol decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: insulin secretion response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: adverse gastro-intestinal effects
Endpoint domain: Adverse events/effects
Primary endpoint: UTI incidence
Endpoint domain: Adverse events/effects
Primary endpoint: time until the first episode of UTI
Endpoint domain: Adverse events/effects
Primary endpoint: Non-dominant upper extremity pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-neutral postures in the non-dominant upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand activity on the non-dominant side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal-replacement therapy usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Renal injury occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: total consumption amount of analgesic drug
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: nausea scores
Endpoint domain: Adverse events/effects
Primary endpoint: DASH questionnaire evaluation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Range-of-motion limitation index (supination movement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of treatment based on House‐Brackmann scale and FDI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine citrate change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAE change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dose of analgesia (morphine/mg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: immediate post-operative serum cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage push time during the cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cycle frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate symptomatic relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Nondiagnostic rate (ND rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance with final diagnosis (CD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical dilatation at diagnosis of preterm labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Duration of gestation after diagnosis of preterm labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: digital blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to sertraline compared to fluoxetine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac events (hospitalization or death for heart failure, sudden death, or CRT-D appropriate interventions)
Endpoint domain: Mortality/survival
Primary endpoint: composite end‐of‐year test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased libido
Endpoint domain: Adverse events/effects
Primary endpoint: Predicted corneal acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of blind vaginal swab technique for detecting bacterial vaginosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Switching treatment due to intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Osteoarticular pain frequency
Endpoint domain: Adverse events/effects
Primary endpoint: stop-signal reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aBMD gain at appendicular skeletal sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sensitivity for T, N and M stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for T, N and M stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unsuspected metastases found
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes